TYSABRI (NATALIZUMAB) IS A PRESCRIPTION MEDICINE USED TO TREAT ADULTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS (MS) TO SLOW SYMPTOM PROGRESSION AND DECREASE FLARE-UPS.
INFUSION THERAPIES: TYSABRI
Metro Infusion Center supports multiple sclerosis patients with a wide range of treatments, including TYSABRI.
THIS LABORATORY-PRODUCED ANTIBODY HAS PROVEN EFFECTIVE IN TREATING MS SYMPTOMS, WHILE PREVENTING RELAPSE, VISION LOSS, AND COGNITIVE DECLINE. IT IS ALSO PRESCRIBED TO TREAT CROHN’S DISEASE.
TYSABRI works by impairing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and brain/spinal cord. Your TYSABRI infusion at Metro Infusion Center is typically administered over one hour every four weeks, plus preparation and observation times.